Last reviewed · How we verify

NCT03535623

RIPC During Free Flap With Preoperative Radiotherapy

Completed NA Last updated 7 May 2024
What this trial tests

NA trial testing remote ischemic preconditioning (RIPC) in Ischemic Reperfusion Injury in 44 participants. Completed in 18 April 2024.

Timeline
29 May 2018
Primary endpoint
20 March 2024
18 April 2024

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment44
Start date29 May 2018
Primary completion20 March 2024
Estimated completion18 April 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

20 and older, any sex, with Ischemic Reperfusion Injury or Other Reconstructive Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Remote ischemic preconditioning (RIPC) has shown organ-protective effects in many clinical settings including patients with ischemic heart disease. However its protective role in head and neck cancer patients with preoperative radiotherapy undergoing free flap reconstructive surgery has not yet been evaluated. The purpose of the current study is to evaluate the effect of RIPC on tissue oxygen saturation and skin temperature of the flap.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Ischemia-reperfusion injury in a rat microvascular skin free flap model: A histological, genetic, and blood flow study.
    Ballestín A, Casado JG, Abellán E, Vela FJ, et al · · 2018 · cited 38× · PMID 30589864 · DOI 10.1371/journal.pone.0209624

Verify or expand the search:

Other trials of remote ischemic preconditioning (RIPC)

Trials testing the same drug.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03535623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing